This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Drug Therapy, Other  • Endocrine Diseases  • Diabetes Mellitus  • Dermatologic Disorders, Other  • Drug Therapy  • Alert me on articles by topic

François Durupt, MD; Stéphane Dalle, MD; Sébastien Debarbieux, MD; Brigitte Balme, MD; Sandra Ronger, MD; Luc Thomas, MD, PhD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Necrobiosis lipoidica (NL) is a rare granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus (DM). The disease is often chronic, and skin lesions can progress toward ulceration and scarring. Many treatments have been proposed, but none show convincing efficacy. We describe herein the first series of patients treated with antimalarial agents for NL. Treatment brought significant improvement for 7 of 8 patients.

Report of Cases

Eight consecutive patients presenting with NL between 1997 and 2004 were studied. All were women and middle-aged (mean age, 40.1 years). Only 1 had a history of DM. All had the skin lesions typical of NL on the anterior aspect of the legs, and 1 patient (in the context of DM) also had 1 plaque on the right forearm. A skin biopsy was performed for . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION